ADTX.US Aditxt Inc.

Healthcare Biotechnology USA Stocks
0.0004 USD
Close of Nov 13, 2026
0.0001 1,048
Market cap
USD 399K
P/E
-
P/B
0.05x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is ADTX.US undervalued?

Graham number

The Graham number of Aditxt Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aditxt Inc. fundamental analysis

No fundamental analysis for Aditxt Inc. yet.

Aditxt Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aditxt Inc.

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, …

Full company profile